search
man and dad heart

Exceptional care

What truly sets the program apart is the strength of multiple heart specialties coming together. Your diagnosis and treatment plan will benefit from the perspective and coordination of four specialties.

Hypertrophic Cardiomyopathy

Early detection saves lives

Hypertrophic cardiomyopathy also may be called HCM. It causes an abnormal thickening of the heart muscle. This can keep the heart from functioning normally. It also can disrupt the electrical currents in the heart. It is the most common inherited heart condition. HCM affects about one person in 500.

This disease is autosomal dominant. That means it requires only one gene from one parent to pass to the child. If one parent has the abnormal gene, each child has a 50 percent chance of inheriting the disease. If one of your parents or siblings has HCM, you should be screened.

Most people with HCM live long and healthy lives. But HCM is the leading cause of sudden cardiac arrest in young athletes. It also can cause:

Why choose The University of Kansas Health System

  • The HCM program at The University of Kansas Health System is a nationally recognized center of excellence.
  • It is the first program of its kind in the region. We address the specific needs of patients and families affected by this complex disease.
  • Our doctors have extensive training in HCM diagnosis and treatment. They have a wealth of experience from years of providing continuing care for hundreds of patients and families.
  • Our experienced nurse clinicians also are knowledgeable about HCM and adult congenital heart disease. They understand your concerns and are happy to answer your questions.
  • What truly sets the program apart is the strength of multiple heart specialties coming together. Most programs include only an electrophysiologist and a surgeon. We include an interventional cardiologist and an echocardiographer, too. Your diagnosis and treatment plan will benefit from the perspective and coordination of four specialties.

Leaders in prevention and treatment

In addition to our expertise with HCM, we are leaders in both prevention and treatment of heart disease.

  • Our Risk Reduction Clinic is devoted to helping people take control of their heart health.
  • We participate in a variety of clinical trials to improve prevention and treatment of heart disease.
  • Our University of Kansas Medical Center partners are known for innovative research into heart disease.
  • People who come to our Regional Heart Attack Center are more likely to survive.
    • In all areas of heart attack care, we exceed the top 10 percent of hospitals nationally. 
    • Our interventional specialists open blocked arteries faster than national standards. 
    • Our patients experience fewer complications than the national average. 
    • Although we take care of sicker patients, our mortality rate for heart attack patients better than the national standard.

Learn more about cardiomyopathy.